Ethiopia declares end to first Marburg outbreak after nine deaths

Ethiopia declared the country’s first recorded outbreak of Marburg virus disease over on Jan. 26, 2026, the World Health Organization said, bringing to a close a flare-up first announced on Nov. 14, 2025 that resulted in at least nine confirmed deaths. The WHO said enhanced surveillance had found no new confirmed cases, signaling that public health measures and case finding were sufficient to interrupt detected chains of transmission.

The announcement marks a rare instance of a filovirus emerging beyond previously recognized hotspots in Central and East Africa. Marburg virus, a close relative of Ebola, causes severe hemorrhagic fever in a subset of infected patients and can overwhelm fragile health systems when cases cluster. While the official death toll is nine confirmed fatalities, the human cost in affected communities extended beyond numbers, as families contended with illness, isolation and economic disruption.

Public health teams deployed to the affected districts carried out case investigation, contact tracing and laboratory testing to identify and isolate cases. Enhanced surveillance by national authorities and international partners involved active monitoring at health facilities and community outreach to detect any new symptoms consistent with Marburg infection. Those steps, the WHO said, found no further confirmed cases, allowing authorities to declare an end to the outbreak.

The episode highlights persistent vulnerabilities in health systems across the region. Ethiopia’s public health infrastructure has improved in recent years, yet laboratory capacity, rapid diagnostic testing and sustained community health worker networks remain uneven, particularly in rural and pastoralist areas where interactions with bat reservoirs of filoviruses are more likely. The emergence of Marburg here underscores the need for sustained investment in integrated disease surveillance, laboratory networks and frontline clinical care.

Equity considerations were central during the response. Communities with limited access to health services faced barriers to early care and testing, increasing the risk of delayed detection. Stigma and fear also complicated efforts to trace contacts and support families, as caregivers and survivors sometimes faced social isolation. Public health experts say that without deliberate policies to build trust and provide economic and psychosocial support, outbreaks can deepen preexisting inequalities.

The regional implications extend beyond borders. East African countries share trade and migration routes, and porous frontiers can allow infectious diseases to move between communities. Strengthening cross-border surveillance and coordinating rapid response efforts will be essential to prevent future spread. The outbreak also reinforces the One Health imperative: surveillance of animal reservoirs, including fruit bats known to carry filoviruses, must be integrated with human health systems to detect and mitigate spillover risk.

Clinically, Marburg remains a disease for which supportive care is the primary effective treatment, and outcomes improve with early recognition and high-quality clinical management. The limited number of deaths in this outbreak reflects, in part, rapid identification and referral of severe cases, though broader access to advanced supportive care remains a challenge in many parts of Ethiopia.

As the country moves from acute response to recovery, public health leaders face choices about strengthening surveillance, expanding laboratory access, investing in health workforce training and addressing social harms experienced during the outbreak. The WHO’s declaration offers a moment to reinforce those investments, not only to prevent another Marburg event, but to improve resilience against the full range of emerging infectious threats that disproportionately affect marginalized communities.